申请人:Allergan, Inc.
公开号:US20130172389A1
公开(公告)日:2013-07-04
The present invention is directed to a compound of Formula I
or a pharmaceutically acceptable salt thereof; wherein R, R
1
, R
2
, R
3
, R
4
, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.
本发明涉及I式化合物或其药学上可接受的盐;其中R,R1,R2,R3,R4,m和n如本文所定义,以及包含该化合物的制药组合物,以及用于治疗由持续钠电流升高介导的疾病或病况的方法,例如眼部疾病,多发性硬化症,癫痫和慢性疼痛。